Takeda Pharmaceutical Co Ltd TAK:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 4:10 PM EDT
14.56quote price arrow up+0.09 (+0.62%)
Volume
1,204,327
52 week range
13.19 - 17.15
Loading...
  • Open14.55
  • Day High14.61
  • Day Low14.54
  • Prev Close14.47
  • 52 Week High17.15
  • 52 Week High Date04/06/23
  • 52 Week Low13.19
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap46.079B
  • Shares Out3.16B
  • 10 Day Average Volume1.55M
  • Dividend0.96
  • Dividend Yield6.58%
  • Beta0.58
  • YTD % Change2.03

KEY STATS

  • Open14.55
  • Day High14.61
  • Day Low14.54
  • Prev Close14.47
  • 52 Week High17.15
  • 52 Week High Date04/06/23
  • 52 Week Low13.19
  • 52 Week Low Date10/26/23
  • Market Cap46.079B
  • Shares Out3.16B
  • 10 Day Average Volume1.55M
  • Dividend0.96
  • Dividend Yield6.58%
  • Beta0.58
  • YTD % Change2.03

RATIOS/PROFITABILITY

  • EPS (TTM)0.40
  • P/E (TTM)36.42
  • Fwd P/E (NTM)0.00
  • EBITDA (TTM)7.835B
  • ROE (TTM)2.76%
  • Revenue (TTM)27.976B
  • Gross Margin (TTM)67.52%
  • Net Margin (TTM)4.28%
  • Debt To Equity (MRQ)69.18%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date09/27/2023
  • Div Amount0.3191
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

 

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Costa Saroukos
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan

Top Peers

SYMBOLLASTCHG%CHG
HLN
HALEON PLC
8.12-0.19-2.29%
BMRN
Biomarin Pharmaceutical Inc
83.81-0.06-0.07%
CTLT
Catalent Inc
55.96-0.26-0.46%
RPRX
Royalty Pharma PLC
30.05-0.04-0.13%
ELAN
Elanco Animal Health Inc
15.78+0.06+0.38%